Roflumilast alternated days
ROFLU2011
Approved small_molecule completed
Quick answer
Roflumilast alternated days for Chronic Obstructive Pulmonary Disease (COPD) is a Approved program (small_molecule) at Lxo Ireland Designated Activity Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lxo Ireland Designated Activity Company
- Indication
- Chronic Obstructive Pulmonary Disease (COPD)
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed